DrugPatentWatch Database Preview
Litigation Details for Takeda Pharmaceutical Co., Ltd. v. Mylan Inc. (N.D. Cal. 2013)
» See Plans and Pricing
Takeda Pharmaceutical Co., Ltd. v. Mylan Inc. (N.D. Cal. 2013)
| Docket | Start Trial | Date Filed | 2013-08-28 |
| Court | District Court, N.D. California | Date Terminated | 2015-04-21 |
| Cause | 35:271 Patent Infringement | Assigned To | Lucy Haeran Koh |
| Jury Demand | Defendant | Referred To | Paul Singh Grewal |
| Patents | 6,462,058; 6,664,276; 6,939,971; 7,285,668; 7,790,755; 8,105,626; 8,173,158; 8,461,187 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Takeda Pharmaceutical Co., Ltd. v. Mylan Inc.
The small molecule drugs covered by the patents cited in this case are Start Trial and Start Trial .
Details for Takeda Pharmaceutical Co., Ltd. v. Mylan Inc. (N.D. Cal. 2013)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2014-11-10 | 145 | asserted patents: U.S. 24 Patent Nos. 6,939,971 (the “’971…CONSTRUING DISPUTED CLAIM TERMS OF U.S. PATENT NOS. 6,939,971, 7,339,064, AND 8,173,158. Signed by Judge… ) TERMS OF U.S. PATENT NOS. 6,939,971, …CONSTRUING DISPUTED CLAIM TERMS OF U.S. PATENT NOS. 6,939,971, 7,339,064, AND …CONSTRUING DISPUTED CLAIM TERMS OF U.S. PATENT NOS. 6,939,971, 7,339,064, AND | External link to document | |
| 2013-10-28 | 30 | Mylan infringed on five other patents associated with Dexilant: 6,462,058; 6,664,276; 6,939,971; … 17 patents 6,462,058; 6,664,276; 6,939,971; 7,285,668; 7,790,755… 8 concerns the patents at issue in the ‘755 Actions and not the patents at issue in the ‘158 Actions…America, Inc. (collectively, “Takeda”) related to patents 22 …alleges that Mylan infringed on two of the Takada patents associated with Dexilant: | External link to document | |
| 2014-08-01 | 84 | noninfringement of U.S. Patent No. 8,105,626. … 25 the patent number and expiration date of any patent that claims the drug or a method… for each patent listed in the Orange Book for the reference-listed drug: (1) that no patent For the Northern…information has been filed, (2) that the patent has expired, (3) that the patent will expire on a United States…a drug . . . claimed in a patent or the use of which is claimed in a patent | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
